CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Predictive Technology Group Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Predictive Technology Group Inc
615 ARAPEEN DRIVE, SUITE 300
Phone: (757) 306-6090p:757 306-6090 SALT LAKE CITY, UT  84108  United States Ticker: PREDPRED
Filed for Bankruptcy on 11/9/2023
This company ceased filing statements with the SEC on 5/20/2022.
Case #23-25147, filed in the U.S. Bankruptcy Court for the District of Utah (Salt Lake City)
On 1/12/2024, the voluntary petition for the Company for reorganization under Chapter 11 was converted to Chapter 7
Business Summary
Predictive Technology Group, Inc. is a life science company. The Company, through its subsidiaries, is focused on specific points of the care continuum, including detection, prevention and treatment. Predictive Analytics, Predictive Laboratories, and Predictive Biotech each bring critical solutions to personalized patient care by leveraging its research, genomics, genetic library and expertise in developing bioscience solutions. Predictive Analytics is the repository for its genetic library. Predictive Biotech provides regenerative medicine. Its products are derived from tissue sources rich in properties that support the body’s natural ability to heal itself. All products are safely, ethically and minimally processed to deliver allografts that preserve the naturally occurring characteristics and factors of the donor tissue. Its research and use of processing methods has propelled its placental-derived and Wharton’s Jelly umbilical cord-derived products to new heights.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20216/30/2020YesYesYesYesYes

Industries
SIC Code Description
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board JohnSorrentino 65 10/1/2018 10/1/2018
President, Chief Executive Officer, Interim Chief Financial Officer, Director Bradley C.Robinson 40 10/1/2021 3/1/2015
CEO of Predictive Therapeutics, Director MichaelDey 68 6/1/2016 6/1/2016
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Predictive Laboratories, Inc. 2735 E Parleys Way Salt Lake City UT United States
Taueret Laboratories, LLC 2749 East Parley's Way Salt Lake City UT United States
Predictive Biotech 615 S Arapeen Dr Salt Lake City UT United States

Business Names
Business Name
Aussie Soles Group Inc.
Aussie Soles Group, Inc.
Aussie Soles International LLC
14 additional Business Names available in full report.

General Information
Number of Employees: 62 (As of 10/7/2020)
Outstanding Shares: 299,596,808 (As of 5/17/2021)
Shareholders: 269
Stock Exchange: OTC
Federal Tax Id: 421767721


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 16, 2024